Hematology / Oncology

1. Kalkanis, A., Palaiodimos, L., Klinaki, I., Karantanis, D., & Kalkanis, D. 18F-FDG PET/CT Imaging of Pulmonary Mucinous Cystadenocarcinoma with Signet Ring Cells. Nuclear Medicine and Molecular Imaging, (2016):1-4.

2. Strakhan, M., Hurtado-Sbordoni, M., Galeas, N., Bakirhan, K., Alexis, K., & Elrafei, T. (2014). 36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature .Case reports in hematology, 2014. PMID 25389502

3. Taveras Alam S, Alexis K, Sridharan A, Strakhan M, Elrafei T, Gralla RJ, Reed LJ. “Acquired Von Willebrand’s Syndrome in Systemic Lupus Erythematosus.” Case Rep Hematol. 2014;2014:208597. PMID: 25544909

4. Armakolas A, Kaparelou M, Dimakakos A, Papageorgiou E, Armakolas N, Antonopoulos A, Petraki C, Lekarakou M, Lelovas P, Stathaki M, Donta I, Galanos PS, Msaouel P, Gorgoulis VG, Koutsilieris M. “Oncogenic role of the Ec peptide of the IGF-1Ec isoform in prostate.” Mol Med. [Epub ahead of print]. PMID: 25569803

5. Heng DY, Signorovitch J, Swallow E, Li N, Zhong Y, Qin P, Zhuo DY, Wang X, Park J, Stergiopoulos S, Kollmannsberger C. “Comparative Effectiveness of Second-Line Targeted Therapies for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World Observational Studies.” PLoS One. 9(12):e114264 (2014). PMID: 25493562

6. Lombard-Bohas C, Yao JC, Hobday T, Van Cutsem E, Wolin EM, Panneerselvam A, Stergiopoulos S, Shah M, Capdevila J, Pommier R. “Impact of Prior Chemotherapy Use on the Efficacy of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-3 Trial.” Pancreas. [Epub ahead of print]. PMID: 25479584

7. Leotsakos I, Dimopoulos P, Gkioka E, Msaouel P, Nezos A, Stravodimos KG, Koutsilieris M, Constantinides CA. “Detection of circulating tumor cells in bladder cancer using multiplex PCR assays.” Anticancer Res. 34(12):7415-24 (2014). PMID: 25503182

8. Domingo-Musibay E, Allen C, Kurokawa C, Hardcastle JJ, Aderca I, Msaouel P, Bansal A, Jiang H, DeGrado TR, Galanis E. “Measles Edmonston vaccine strain derivatives have potent oncolytic activity against osteosarcoma.” Cancer Gene Ther. 21(11):483-90 (2014). PMID: 25394505

9. Gralla RJ, Hollen PJ, Msaouel P, Davis BV, Petersen J. “An evidence-based determination of issues affecting quality of life and patient-reported outcomes in lung cancer: results of a survey of 660 patients.” J Thorac Oncol. 9(9):1243-8 (2014). PMID: 25122420

10. Shenoy N, Vallumsetla N, Rachmilewitz E, Verma A, Ginzburg Y. “Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome.” Blood. 2014 [Epub ahead of print]. PMID: 24923296

11. Hu C, Mohtat D, Yu Y, Ko YA, Shenoy N, Bhattacharyya S, Izquierdo MC, Park AS, Giricz O, Vallumsetla N, Gundabolu K, Ware K, Bhagat T, Suzuki M, Pullman J, Liu SX, Greally J, Susztak K, Verma A. “Kidney cancer is characterized by aberrant methylation of tissue specific enhancers that are prognostic for overall survival.” Clin Cancer Res. 2014 [Epub ahead of print]. PMID: 24916699

12. Karavitakis M, Msaouel P, Michalopoulos V, Koutsilieris M. “Pattern of Somatostatin Receptors Expression in Normal and Bladder Cancer Tissue Samples.” Anticancer Res. 34(6):2937-2942 (2014). PMID: 24922657

13. Gralla RJ, Bosnjak SM, Honsta A, Balser C, Rizzi G, Rossi G, Borroni ME, Jordan K. “A Phase 3 study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting (CINV) over repeated cycles of chemotherapy.” Annals of Oncology 2014. [Epub ahead of print]. PMID: 24631949.

14. Msaouel P, Lam AP, Gundabolu K, Chrysofakis G, Yu Y, Mantzaris I, Friedman E, Verma A. “Abnormal platelet count is an independent predictor of mortality in the elderly and is influenced by ethnicity.” Haematologica. 99(5):930-6 (2014). PMID: 24510340

15. Tamari R, Schinke C, Bhagat T, Roth M, Braunschweig I, Will B, Steidl U, Verma A. “Eltrombopag can overcome the anti-megakaryopoietic effects of lenalidomide without increasing proliferation of the malignant myelodysplastic syndrome/acute myelogenous leukemia clone.” Leuk Lymphoma. (2014) [Epub ahead of print] PMID: 24650011

16. Hesketh PJ, Rossi G, Rizzi G, Palmas M, Alyasova A, Bondarenko I,Lisyanskaya A, Gralla RJ. “Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: A randomized dose-ranging pivotal study.” Annals of Oncology (2014). [Epub ahead of print] PMID: 24608196.

17. Elias HK, Schinke C, Bhattacharyya S, Will B, Verma A, Steidl U. “Stem cell origin of myelodysplastic syndromes.” Oncogene. (2013) [Epub ahead of print] PMID: 24336326

18. Jordan K, Gralla R, Jahn F, Molassiotis A. “International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice.” Eur J Pharmacol. Jan 5;722:197-202 (2014). PMID: 24157984

19. Visentin M, Unal ES, Goldman ID. “The impact of 5-formyltetrahydrofolate on the anti-tumor activity of pralatrexate, as compared to methotrexate, in HeLa cells in vitro.” Cancer Chemother Pharmacol. 2014 Mar 29. [Epub ahead of print] PMID: 24682532

20. Morse KD, Gralla RJ, Petersen JA, Rosen LM. “Preferences for cancer support group topics and group satisfaction among patients and caregivers.” J Psychosoc Oncol. 32(1):112-23 (2014).

21. Cardoso F, Bese N, Distelhorst SR, Bevilacqua JL, Ginsburg O, Grunberg SM, Gralla RJ, Steyn A, Pagani O, Partridge AH, Knaul FM, Aapro MS, Andersen BL, Thompson B, Gralow JR, Anderson BO. “Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement.” Breast. Oct;22(5):593-605 (2013). PMID: 24001709

22. Papaoiconomou E, Lymperi M, Petraki C, Philippou A, Msaouel P, Michalopoulou F, Kafiri G, Vassilakos G, Zografos G, Koutsilieris M. “Kiss-1/GPR54 Protein Expression in Breast Cancer.” Anticancer Res. 34(3):1401-7 (2014). PMID: 24596387

23. Opyrchal M, Allen C, Msaouel P, Iankov I, Galanis E. “Inhibition of Rho-associated coiled-coil-forming kinase increases efficacy of measles virotherapy.” Cancer Gene Ther. 20(11):630-7 (2013). PMID: 24157925

24. Pneumaticos SG, Christofides A, Gkioka E, Kalogeropoulos T, Msaouel P, Koutsilieris M. “Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications.” Expert Opin Ther Targets. 17(12):1395-403 (2013). PMID: 24024908

25. Msaouel P, Nandikolla G, Pneumaticos SG, Koutsilieris M. “Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer.” Expert Opin Investig Drugs. 22(11):1385-400 (2013). PMID: 24024652

26. Bachegowda L, Gligich O, Mantzaris I, Schinke C, Wyville D, Carrillo T, Braunschweig I, Steidl U, Verma A. “Signal transduction inhibitors in treatment of myelodysplastic syndromes.” J Hematol Oncol. 6:50 (2013). PMID: 23841999

27. Ferastraoaru DE, Dickler MN, Patel S, Fischer EA, Pulitzer MP, Myskowski PL, Jerschow E. “Nonimmediate hypersensitivity reaction after trastuzumab infusion: a suspected drug-virus interaction.” J Clin Oncol. 20;31(24):e407-9 (2013). PMID: 23752107

28. Bakirhan K, Strakhan M. “Pharmacologic prevention of venous thromboembolism in obese patients.” J Thromb Thrombolysis. 36(3):247-57 (2013). PMID: 23180282

29. K Rishikesh, U Kini, N Shenoy, B Joy, G D’Souza, A Shet. “Malignant Pleural Mesothelioma”. Journal of Association of Physicians of India Vol 61 (Aug 2013)

30. Lam AP, Gundabolu K, Sridharan A, Jain R, Msaouel P, Chrysofakis G, Yu Y, Friedman E, Price E, Schrier S, Verma AK. “Multiplicative interaction between mean corpuscular volume and red cell distribution width in predicting mortality of elderly patients with and without anemia.” Am J Hematol. 88(11):E245-9 (2013). PMID: 23828763

31. Savvani A*, Petraki C*, Msaouel P*, Diamanti E, Xoxakos I, Koutsilieris M. “IGF-IEc Expression Is Associated with Advanced Clinical and Pathological Stage of Prostate Cancer.” Anticancer Res. Jun;33(6):2441-5 (2013). PMID: 23749893
32. *The first three authors contributed equally to this work.

33. Msaouel P, Opyrchal M, Domingo E, Galanis E. “Oncolytic Measles Virus Strains as Novel Anticancer Agents”. Expert Opinion on Biological Therapy Apr;13(4):483-502 (2013). PMID: 23289598

34. Feld J, Barta SK, Schinke C, Braunschweig I, Zhou Y, Verma AK. “Linked-in: design and efficacy of antibody drug conjugates in oncology.” Oncotarget. 4(3):397-412 (2013). PMID: 23651630

35. Visentin M, Unal ES, Zhao R, Goldman ID. “The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor.” Cancer Chemother Pharmacol. 72(3):597-606 (2013). PMID: 23881211

36. Lee CK, Brown C, Gralla RJ, Hirsh V, Thongprasert S, Tsai CM, Tan EH, Ho JC, Chu da T, Zaatar A, Osorio Sanchez JA, Vu VV, Au JS, Inoue A, Lee SM, Gebski V, Yang JC. “Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis.” J Natl Cancer Inst. May 1;105(9):595-605 (2013). PMID: 23594426

37. Hollen PJ, Gralla RJ, Jones RA, Thomas CY, Brenin DR, Weiss GR, Schroen AT, Petroni GR. “A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer.” Support Care Cancer. Mar;21(3):889-99 (2013). PMID: 23052911

38. Heuck CJ, Mehta J, Bhagat T, Gundabolu K, Yu Y, Khan S, Chrysofakis G, Schinke C, Tariman J, Vickrey E, Pulliam N, Nischal S, Zhou L, Bhattacharyya S, Meagher R, Hu C, Maqbool S, Suzuki M, Parekh S, Reu F, Steidl U, Greally J, Verma A, Singhal SB. “Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis.” J Immunol. 190(6):2966-75 (2013). PMID: 23408834

39. Hollen PJ, Gralla RJ, Stewart JA, Meharchand JM, Wierzbicki R, Leighl N. “Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL).” Support Care Cancer. Jan;21(1):165-72 (2013). PMID: 22684988

40. Alappan N, Marak CP, Chopra A, Joy PS, Dorokhova O, Guddati AK. “Renal medullary cancer in a patient with sickle cell trait.” Case Rep Oncol Med. 2013:129813 (2013). PMID: 24222876

41. Nischal S, Bhattacharyya S, Christopeit M, Yu Y, Zhou L, Bhagat TD, Sohal D, Will B, Mo Y, Suzuki M, Pardanani A, McDevitt M, Maciejewski JP, Melnick AM, Greally JM, Steidl U, Moliterno A, Verma A. “Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms.” Cancer Res. 73(3):1076-85 (2013). PMID: 23066032.

42. Gralla RJ. “Palliative care: Aprepitant and control of emesis induced by 5-day chemotherapy.” Nat Rev Clin Oncol. Nov;9(11):614-6 (2012). PMID: 23070254

43. Will B, Zhou L, Vogler TO, Ben-Neriah S, Schinke C, Tamari R, Yu Y, Bhagat TD, Bhattacharyya S, Barreyro L, Heuck C, Mo Y, Parekh S, McMahon C, Pellagatti A, Boultwood J, Montagna C, Silverman L, Maciejewski J, Greally JM, Ye BH, List AF, Steidl C, Steidl U, Verma A. “Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.” Blood. 120(10):2076-86 (2012). PMID: 22753872

44. Barginear MF, Gralla RJ, Bradley TP, Ali SS, Shapira I, Greben C, Nier-Shoulson N, Ackerman M, Lesser M, Budman DR. “Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial.” Supportive Care in Cancer. 20:2865 – 2872 (2012). PMID: 22421738

45. Gralla RJ. “Coming of Age for Monitoring Quality of Life and Patient-Reported Outcomes.” Journal of Thoracic Oncology 7: 8-9 (2012). PMID:22173660

46. Barta SK, Zou Y, Schindler J, Shenoy N, Bhagat TD, Steidl U, Verma A. “Synergy of sequential administration of a deglycosylated ricin A chain-containing combined anti-CD19 and anti-CD22 immunotoxin (Combotox) and cytarabine in a murine model of advanced acute lymphoblastic leukemia.” Leuk Lymphoma. 2012 Oct;53(10):1999-2003. PMID: 22448921

47. Shenoy N, Kessel R, Bhagat TD, Bhattacharyya S, Yu Y, McMahon C, Verma A. “Alterations in the ribosomal machinery in cancer and hematologic disorders.” J Hematol Oncol. Jun 18;5:32
48. (2012). PMID: 22709827

49. Papadantonakis N, Matsuura S, Ravid K. “Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connection.” Blood. 120(9):1774-81 (2012). PMID: 22767499

50. Toulis K, Goulis DG, Msaouel P, Koutsilieris M. “Dexamethasone plus Somatostatin-analogue manipulation as a bone metastasis micro-environment targeting therapy for the treatment of castration-resistant prostate cancer patients: a meta-analysis of uncontrolled studies.” Anticancer Res. 32(8):3283-9 (2012). PMID: 22843903

51. Evangelou I, Petraki C, Msaouel P, Scorilas A, Sdrolia E, Padazi G, Koborozos V, Koutsilieris M. “Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancer” European Journal of Clinical Investigation Eur J Clin Invest. 42(7):777-83 (2012). PMID: 22304674

52. Msaouel P, Iankov ID, Dispenzieri A., Galanis E. “Attenuated oncolytic Measles Virus strains as cancer therapeutics.” Current Pharmaceutical Biotechnology 13(9):1732-41 (2012). PMID: 21740361

53. Roila F, Herrstedt J, Gralla RJ, and Tonato M. “Prevention of chemotherapy- and radiotherapy- induced nausea and vomiting: Guideline update and results of the Perugia consensus conference.” Supportive Care in Cancer 19: S63 – S65 (2011). PMID:21188425

54. Zhou L, Opalinska J, Sohal D, Yu Y, Mo Y, Bhagat T, Abdel-Wahab O, Fazzari M, Figueroa M, Alencar C, Zhang J, Kambhampati S, Parmar S, Nischal S, Hueck C, Suzuki M, Freidman E, Pellagatti A, Boultwood J, Steidl U, Sauthararajah Y, Yajnik V, McMahon C, Gore SD, Platanias LC, Levine R, Melnick A, Wickrema A, Greally JM, Verma A. “Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q.” J Biol Chem. 286(28):25211-23 (2011). PMID: 21532034

55. Roila F, Warr D, Aapro M, Clark-Snow RA, Einhorn L, Gralla RJ, Herrstedt J, Saito M, and Tonato M. Delayed emesis: moderately emetic chemotherapy (single-day chemotherapy regimens only). Supportive Care in Cancer 19: S57 – S62 (2011). PMID:20574663

56. Grunberg SM, Warr D, Gralla RJ, Rapoport BL, Hesketh PJ, Jordan K, and Espersen BT. “Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity – state of the art.” Supportive Care in Cancer 19: S43 – S47 (2011). PMID:20972805

57. Reed LJ, Raghupathy R, Strakhan M, Philbeck TE, Kim MY, Battini R, Hussain Z, Abdullah S, Schweber S, Bala K, Pacello T. “The OnControl bone marrow biopsy technique is superior to the standard manual technique for hematologists-in-training: a prospective, randomized comparison.” Hematol Rep. 3(3):e21 (2011). PMID: 22593813

58. Alvarez H, Opalinska J, Zhou L, Sohal D, Fazzari MJ, Yu Y, Montagna C, Montgomery EA, Canto M, Dunbar KB, Wang J, Roa JC, Mo Y, Bhagat T, Ramesh KH, Cannizzaro L, Mollenhauer J, Thompson RF, Suzuki M, Meltzer SJ, Melnick A, Greally JM, Maitra A, Verma A. “Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis.” PLoS Genet. 7(3):e1001356 (2011). PMID: 21483804

59. Eliades A, Papadantonakis N, Bhupatiraju A, Burridge KA, Johnston-Cox HA, Migliaccio AR, Crispino JD, Lucero HA, Trackman PC, Ravid K. “Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase.” J Biol Chem. 286(31):27630-8 (2011). PMID: 21665949

60. Zhou L, McMahon C, Bhagat T, Alencar C, Yu Y, Fazzari M, Sohal D, Heuck C, Gundabolu K, Ng C, Mo Y, Shen W, Wickrema A, Kong G, Friedman E, Sokol L, Mantzaris I, Pellagatti A, Boultwood J, Platanias LC, Steidl U, Yan L, Yingling JM, Lahn MM, List A, Bitzer M, Verma A. “Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase.” Cancer Res. 71(3):955-63 (2011). PMID: 21189329

61. Msaouel P, Koutsilieris M. “Diagnostic Value of Circulating Tumor Cell Detection in Bladder and Urothelial Cancer: Systematic Review and Meta-analysis.”. BMC Cancer 11(1):336 (2011). PMID: 21816094

62. Shin DS, Mahadeo K, Min SH, Diop-Bove N, Clayton P, Zhao R, Goldman ID. “Identification of novel mutations in the proton-coupled folate transporter (PCFT-SLC46A1) associated with hereditary folate malabsorption.” Mol Genet Metab. 103(1):33-7 (2011). PMID: 21333572

63. Goldman ID, Chattopadhyay S, Zhao R, Moran R. “The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs.” Curr Opin Investig Drugs. 11(12):1409-23 (2010). PMID: 21154123

64. Schinke C, Goel S, Bhagat TD, Zhou L, Mo Y, Gallagher R, Kabalka GW, Platanias LC, Verma A, Das B. “Design and synthesis of novel derivatives of all-trans retinoic acid demonstrate the combined importance of acid moiety and conjugated double bonds in its binding to PML-RAR-alpha oncogene in acute promyelocytic leukemia.” Leuk Lymphoma. 51(6):1108-14 (2010). PMID: 20536349

65. Eliades A, Papadantonakis N, Ravid K. “New roles for cyclin E in megakaryocytic polyploidization.” J Biol Chem. 285(24):18909-17 (2010). PMID: 20392692

66. Schinke C, Mo Y, Yu Y, Amiri K, Sosman J, Greally J, Verma A. “Aberrant DNA methylation in malignant melanoma.” Melanoma Res. 20(4):253-65 (2010). PMID: 20418788

67. Gopal M, Abdullah SE, Grady JJ, Goodwin JS. “Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials.” J Thorac Oncol. 5(8):1233-9 (2010). PMID: 20548246

68. Shin DS, Min SH, Russell L, Zhao R, Fiser A, Goldman ID. “Functional roles of aspartate residues of the proton-coupled folate transporter (PCFT-SLC46A1); a D156Y mutation causing hereditary folate malabsorption.” Blood. 116(24):5162-9 (2010). PMID: 20805364

69. Avritscher EB, Shih YC, Sun CC, Gralla RJ, Grunberg SM, Xu Y, Elting LS. “Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients.” Journal of Supportive Oncology 6:242-51 (2010). PMID:21265391

70. Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D. “Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.” Annals of Oncology 21: 232–243 (2010). PMID:20555089

71. Zhao R, Min SH, Wang Y, Campanella E, Low PS, Goldman ID. “A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis.” J Biol Chem. 284(7):4267-74 (2009). PMID: 19074442

72. Bria E, Gralla RJ, Raftopoulos H, Cuppone F, Milella M, Sperduti I, Carlini P, Terzoli E, Cognetti F, Giannarelli D. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials. Lung Cancer 63:50-57 (2009). PMID:18565615

73. Gralla RJ, Raftopoulos H. “Progress in the Control of Chemotherapy-Induced Emesis: New Agents and New Studies.” Journal of Oncology Practice 5: 130-133 (2009).

74. Barginear MF, Lesser M, Akerman ML, Strakhan M, Shapira I, Bradley T, Budman DR. “Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcome.” Clin Appl Thromb Hemost. 15(3):263-9 (2009). PMID: 18385149

75. Rivera MP, Detterbeck FC, Socinski MA, Moore DT, Edelman MJ, Jahan TM, Ansari RH, Luketich JD, Peng G, Monberg M, Obasaju CK, Gralla RJ. “Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer”. Chest 6:1588-95 (2009). PMID: 19188545

76. Gralla RJ, Edelman MJ, Detterbeck FC, Jahan TM, Loesch DM, Limentani SA, Govindan R, Peng G, Monberg MJ, Obasaju CK, Socinski MA. “Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS).” Supportive Care in Cancer 17:307-13 (2009). PMID:18781341